These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Abnormal clones of megakaryocytes in myeloproliferative disorders. Sato Y; Suda T Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1705-18. PubMed ID: 3471029 [No Abstract] [Full Text] [Related]
66. Extramedullary haematopoietic tumour of the breast: a case report in a woman with secondary myelofibrosis following essential thrombocythaemia. Al-Nafussi A; Al-Okati D; Alsewan M Histopathology; 2004 Jun; 44(6):625-6. PubMed ID: 15186279 [No Abstract] [Full Text] [Related]
68. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients. Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904 [TBL] [Abstract][Full Text] [Related]
69. [Essential thrombocythemia transformed to myelofibrosis with myeloid metaplasia after seven years]. Yamagishi M; Yamamoto T; Ohmori M Rinsho Ketsueki; 1991 Mar; 32(3):239-43. PubMed ID: 2041165 [TBL] [Abstract][Full Text] [Related]
70. Classification of myeloproliferative disorders by bone marrow histology. Frisch B; Bartl R; Burkhardt R; Jäger K; Mahl G; Kettner G Bibl Haematol; 1984; (50):57-80. PubMed ID: 6590039 [No Abstract] [Full Text] [Related]
71. Myelofibrosis in the myeloproliferative disorders. Ellis JT; Peterson P Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293 [TBL] [Abstract][Full Text] [Related]
72. Aberrant proplatelet formation in chronic myeloproliferative neoplasms. Muth M; Büsche G; Bock O; Hussein K; Kreipe H Leuk Res; 2010 Nov; 34(11):1424-9. PubMed ID: 20430444 [TBL] [Abstract][Full Text] [Related]
73. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-1992. Repeated bouts of hematochezia in an 80-year-old hypertensive man. N Engl J Med; 1992 Apr; 326(17):1137-46. PubMed ID: 1552915 [No Abstract] [Full Text] [Related]
74. Essential thrombocythaemia with aggressive megakaryocytosis after myelofibrotic transformation. Sasaki K; Nannya Y; Nakamura Y; Ichikawa M; Ogawa S; Mitani K Hematology; 2021 Dec; 26(1):594-600. PubMed ID: 34402416 [TBL] [Abstract][Full Text] [Related]
75. Modern diagnostics in chronic myeloproliferative diseases (CMPDs). Haferlach T; Kern W; Schnittger S; Schoch C Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674 [TBL] [Abstract][Full Text] [Related]
76. [Osteomyelofibrosis as a prognostic factor in myeloproliferative diseases?]. Wehmeier A; Schneider W Dtsch Med Wochenschr; 1993 May; 118(21):804-5. PubMed ID: 8504717 [No Abstract] [Full Text] [Related]
77. Circulating hematopoietic progenitor cells in essential thrombocythemia versus prefibrotic/early primary myelofibrosis. Geissler K; Jäger E; Gisslinger B; Thiele J; Schwarzinger I; Gisslinger H Am J Hematol; 2014 Dec; 89(12):1157-8. PubMed ID: 25112775 [No Abstract] [Full Text] [Related]
78. Essential thrombocythemia: a hypercoagulable state. Hunter Mellado RF; Oppenheimer Catalá J; Vázquez Medina J Bol Asoc Med P R; 1991 Oct; 83(10):436-9. PubMed ID: 1789889 [TBL] [Abstract][Full Text] [Related]
79. [Essential thrombocythemia]. Krupsky M; Berrebi A Harefuah; 1987 Mar; 112(6):268-72. PubMed ID: 3609955 [No Abstract] [Full Text] [Related]